Skip to main navigation Skip to search Skip to main content

Malathion for head lice and scabies: Treatment and safety considerations

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Malathion is an under-recognized and under-utilized therapy for head lice and scabies largely due to misperceptions about its safety profile. Specifically, its pure form as it exists in pharmaceutical preparations is non-toxic to humans in the low doses available. While labeled for ages six and up, recent studies showed no cholinesterase inhibition in head lice patients aged two-to-six treated with malathion. Flammability of malathion in isopropyl alcohol has reportedly resulted in human injury once in over one million prescriptions filled. Recent efficacy studies of malathion in United States (U.S.) head lice demonstrate efficacy rates of 97-98%. In the present era of permethrin and lindane resistance to head lice, malathion is a first-line option. For scabies, it is a reasonable alternative to permethrin 5% cream, especially when treatment of the scalp or hairy areas is desired.

Original languageEnglish
Pages (from-to)715-720
Number of pages6
JournalJournal of Drugs in Dermatology
Volume8
Issue number8
StatePublished - Aug 2009

Fingerprint

Dive into the research topics of 'Malathion for head lice and scabies: Treatment and safety considerations'. Together they form a unique fingerprint.

Cite this